Overview SP2086 Pharmacokinetic Study in Renal Insufficiency Patients Status: Completed Trial end date: 2015-01-01 Target enrollment: Participant gender: Summary The purpose of the study is to investigate the SP2086 pharmacokinetic in Renal Insufficiency Patients. Phase: Phase 1 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.